GEORGE W. THORN, F.A.C.P.; SAMUEL S. DORRANCE; EMERSON DAY
This content is PDF only. Please click on the PDF icon to access.
The immediate and favorable response of patients with Addison's disease to synthetic desoxycorticosterone acetate therapy is now well established.1, 2, 3, 4, 5 The effect which treatment with desoxycorticosterone acetate will have on the life expectancy of patients with Addison's disease cannot be stated at this early date, although our experience indicates that there has been a considerable reduction in mortality rate during the first 18 months of therapy.
The present report summarizes our experience with synthetic desoxycorticosterone acetate therapy during the past three years. In this period 158 patients with classical signs and symptoms of Addison's disease have
THORN GW, DORRANCE SS, DAY E. ADDISON'S DISEASE: EVALUATION OF SYNTHETIC DESOXYCORTICOSTERONE ACETATE THERAPY IN 158 PATIENTS*. Ann Intern Med. 1942;16:1053–1096. doi: https://doi.org/10.7326/0003-4819-16-6-1053
Download citation file:
Published: Ann Intern Med. 1942;16(6):1053-1096.
Adrenal Disorders, Endocrine and Metabolism.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use